skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Examination of GyE system for HIMAC carbon therapy

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1];  [2];  [3];  [3];  [3];  [3];  [3];  [3];  [3]
  1. Department of Medical Physics, National Institute of Radiological Sciences, Chiba (Japan)
  2. Department of Accelerator Physics and Engineering, National Institute of Radiological Sciences, Chiba (Japan)
  3. Department of Hospital, Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba (Japan)

Purpose: A retrospective analysis was made to examine appropriateness in the estimation of the biologic effectiveness of carbon-ion radiotherapy using resultant data from clinical trials at the heavy-ion medical accelerator complex (HIMAC) at the National Institute of Radiological Sciences in Chiba, Japan. Methods and Materials: At HIMAC, relative biologic effectiveness (RBE) values of therapeutic carbon beams were determined based on experimental results of cell responses, on values expected with the linear-quadratic model, and based on experiences with neutron therapy. We use fixed RBE values independent of dose levels, although this apparently contradicts radiobiologic observations. Our RBE system depends only on LET of the heavy-ion radiation fields. With this RBE system, over 2,000 patients have been treated by carbon beams. With data from these patients, the local control rate of non-small-cell lung cancer was analyzed to verify the clinical RBE of the carbon beam. The local control rate was compared with rates published by groups from Gunma University and Massachusetts General Hospital. Using a simplified tumor control probability (TCP) model, clinical RBE values were obtained for different levels of TCP. Results: For the 50% level of the clinical TCP, the RBE values nearly coincide with those for in vitro human salivary gland cell survival at 10%. For the higher levels of clinical TCP, the RBE values approach closer to those adapted in clinical trials at HIMAC.

OSTI ID:
20793328
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 64, Issue 2; Other Information: DOI: 10.1016/j.ijrobp.2005.09.043; PII: S0360-3016(05)02726-4; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

Mapping of RBE-Weighted Doses Between HIMAC- and LEM-Based Treatment Planning Systems for Carbon Ion Therapy
Journal Article · Thu Nov 01 00:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20793328

Carbon Beam Radio-Therapy and Research Activities at HIMAC
Journal Article · Tue May 22 00:00:00 EDT 2007 · AIP Conference Proceedings · OSTI ID:20793328

Fast neutron radiotherapy: For equal or for better
Journal Article · Sun Nov 01 00:00:00 EST 1981 · Med. Phys.; (United States) · OSTI ID:20793328